APA

Pirazzoli V., Nebhan C., Song X., Wurtz A., Walther Z., Cai G., Zhao Z., Jia P., de Stanchina E., Shapiro E. M., Gale M., Yin R., Horn L., Carbone D. P., Stephens P. J., Miller V., Gettinger S., Pao W. & Politi K. (20150420). Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. : Cell reports.

Chicago

Pirazzoli Valentina, Nebhan Caroline, Song Xiaoling, Wurtz Anna, Walther Zenta, Cai Guoping, Zhao Zhongming, Jia Peilin, de Stanchina Elisa, Shapiro Erik M, Gale Molly, Yin Ruonan, Horn Leora, Carbone David P, Stephens Philip J, Miller Vincent, Gettinger Scott, Pao William and Politi Katerina. 20150420. Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. : Cell reports.

Harvard

Pirazzoli V., Nebhan C., Song X., Wurtz A., Walther Z., Cai G., Zhao Z., Jia P., de Stanchina E., Shapiro E. M., Gale M., Yin R., Horn L., Carbone D. P., Stephens P. J., Miller V., Gettinger S., Pao W. and Politi K. (20150420). Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. : Cell reports.

MLA

Pirazzoli Valentina, Nebhan Caroline, Song Xiaoling, Wurtz Anna, Walther Zenta, Cai Guoping, Zhao Zhongming, Jia Peilin, de Stanchina Elisa, Shapiro Erik M, Gale Molly, Yin Ruonan, Horn Leora, Carbone David P, Stephens Philip J, Miller Vincent, Gettinger Scott, Pao William and Politi Katerina. Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1. : Cell reports. 20150420.